hat
te Palmitòyl tetrapèptid-7 konsidere yo yon sibstans ki sou preferab pou itilize nan pwodwi kosmetik akòz kapasite li yo anba po ak delivre lòt engredyan anti aje pi fon nan tisi po. Bon jan kalite a nan solubility nan lwil fè li yon chwa ideyal nan sentèz ak konpoze komen yo itilize nan pwodwi dermatologique espesyalman anti pwodwi aje, depi melanj yo gen plis chans yo rete omojèn. Pou w jwenn rapò a plen ki antoure pwoblèm toksik, efè segondè posib akòz itilize pwolonje ak lòt faktè, sa a Palmitòyl tetrapèptid-7 te soumèt anba Pwogram Enskripsyon Volontè kosmetik nan 2012 pou apwobasyon FDA.
eng
Palmitoyl tetrapeptide-7 was considered to a preferable substance for use in cosmetic products due to its ability to penetrate skin and deliver other anti aging ingredients deeper into skin tissues. The quality of solubility in oil makes it an ideal choice of synthesis with common compounds used in dermatological products especially anti aging products, since the mixtures are more likely to stay homogenous. To obtain the full report surrounding toxicological issues, possible side effects due to prolonged use and other factors, this palmitoyl tetrapeptide-7 was submitted under the Voluntary Cosmetic Registration Program in 2012 for FDA approval.